Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velneperit OLE in Obesity
NCT00788528Phase 2Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Aug 2008
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of velneperit in obesity, sponsored by Shionogi & Co., Ltd. Primary endpoints: Change in body weight at 54 weeks and Treatment-emergent adverse events. Started Aug 2008; status: completed.
02
Drugs
velneperit
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00788528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00788528.